DENTSPLY SIRONA (NASDAQ:XRAY) Announces Earnings Results, Beats Expectations By $0.02 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) announced its earnings results on Thursday. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02, Briefing.com reports. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same period last year, the firm posted $0.49 EPS. The business’s revenue was up .4% compared to the same quarter last year. DENTSPLY SIRONA updated its FY 2024 guidance to 1.820-1.860 EPS and its FY24 guidance to $1.82-$1.86 EPS.

DENTSPLY SIRONA Trading Up 3.5 %

Shares of NASDAQ XRAY traded up $0.60 during midday trading on Friday, reaching $17.86. The company had a trading volume of 9,406,034 shares, compared to its average volume of 3,113,741. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The firm’s fifty day moving average price is $24.82 and its 200-day moving average price is $25.98. The stock has a market cap of $3.62 billion, a PE ratio of -8.63, a price-to-earnings-growth ratio of 1.31 and a beta of 1.02. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $37.60.

Analysts Set New Price Targets

XRAY has been the topic of a number of recent research reports. Evercore ISI dropped their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Needham & Company LLC cut their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Wednesday. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday. Finally, Robert W. Baird decreased their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $29.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.